참고문헌
- Albertson, D.G. (2006). Gene amplification in cancer. Trends Genet. 22, 447-455. https://doi.org/10.1016/j.tig.2006.06.007
- Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.Y., Sauter, G., Kallioniemi, O.P., Trent, J.M., and Meltzer, P.S. (1997). AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277, 965-968. https://doi.org/10.1126/science.277.5328.965
- Bautista, S., Valles, H., Walker, R. L., Anzick, S., Zeillinger, R., Meltzer, P., and Theillet, C. (1998). In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res. 4. 2925-2929.
- Easton, D.F., Bishop, D.T., Ford, D., and Crockford, G.P. (1993). Genetic linkage analysis in familial breast and ovarian cancer:results from 214 families. The Breast Cancer Linkage Consortium. Am. J. Hum Genet. 52, 678-701.
- Hortobagyi, G.N. (1998). Treatment of breast cancer. New Engl. J. Med. 339, 974-984. https://doi.org/10.1056/NEJM199810013391407
- Kranzfelder, M., Schuster, T., Geinitz, H., Friess, H., and Buchler, P. (2011). Meta‐analysis of neoadjuvant treatment modalities and definitive non‐surgical therapy for oesophageal squamous cell cancer. Brit. J. Surg. 98, 768-783. https://doi.org/10.1002/bjs.7455
-
Livak K.J., and Schmittgen T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the
$2-^{{\Delta}{\Delta}Ct}$ method. Methods 25, 402-408. https://doi.org/10.1006/meth.2001.1262 - Louie, M.C., Zou, J.X., Rabinovich, A., and Chen, H.W. (2004). ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance. Mol. Cell Biol. 24, 5157-5171. https://doi.org/10.1128/MCB.24.12.5157-5171.2004
- Mavaddat, N., Pharoah, P.D., Blows F., Driver, K.E., Provenzano, E., Thompson, D., Macinnis, R.J., Shah, M., Easton, D.F., and Antoniou, A.C. (2010). Familial relative risks for breast cancer by pathological subtype: a population-based cohort study. Breast Cancer Res. 12, R10. https://doi.org/10.1186/bcr2476
- McPherson, K., Steel, C. and Dixon, J. (2000). ABC of breast diseases: breast cancer-epidemiology, risk factors, and genetics. BMJ-Brit. Med. J. 321, 624. https://doi.org/10.1136/bmj.321.7261.624
- Miki, Y., Swensen, J., Shattuck-Eidens. D., Futreal, P.A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L.M., Ding, W., et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66-71. https://doi.org/10.1126/science.7545954
- Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005). Global cancer statistics, 2002. CA-Cancer J. Clin. 55, 74-108. https://doi.org/10.3322/canjclin.55.2.74
- Sakaguchi, H., Fujimoto, J., Sun, W.S., and Tamaya, T. (2007). Clinical implications of steroid receptor coactivator (SRC)-3 in uterine endometrial cancers. J. Steroid Biochem. Mol. Biol. 104, 240.
- Santarius, T., Shipley, J., Brewer, D., Stratton, M.R., and Cooper, C.S. (2010). A census of amplified and overexpressed human cancer genes. Nat. Rev. Cancer 10, 59-64. https://doi.org/10.1038/nrc2771
- Thompson, D., and Easton, D. (2004). The genetic epidemiology of breast cancer genes. J. Mammary Gland. Biol. 9, 221-236. https://doi.org/10.1023/B:JOMG.0000048770.90334.3b
- Weigelt, B., Peterse, J.L., and van't Veer, L.J. (2005). Breast cancer metastasis: markers and models. Nat. Rev. Cancer 5, 591-602. https://doi.org/10.1038/nrc1670
- Werbajh, S., Nojek, I., Lanz, R., and Costas, M.A. (2000). RAC-3 is a NF-kappa B coactivator. FEBS Lett. 485, 195-199. https://doi.org/10.1016/S0014-5793(00)02223-7
- Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., and Micklem, G. (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789-792. https://doi.org/10.1038/378789a0
- Yan, J., Yu, C.T., Ozen, M., Ittmann, M., Tsai, S.Y., and Tsai, M.J. (2006). Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulinlike growth factor/AKT signaling pathway. Cancer Res. 66, 11039-11046. https://doi.org/10.1158/0008-5472.CAN-06-2442
- Zhou, H.J., Yan, J., Luo, W., Ayala, G., Lin, S.H., Erdem, H., Ittmann, M., Tsai, S.Y., and Tsai, M.J. (2005). SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 65, 7976-7983. https://doi.org/10.1158/0008-5472.CAN-04-4076
피인용 문헌
- SRC-3, a Steroid Receptor Coactivator: Implication in Cancer vol.22, pp.9, 2016, https://doi.org/10.3390/ijms22094760
- AIB1 induces epithelial‐mesenchymal transition in gastric cancer via the PI3K/AKT signaling vol.122, pp.9, 2016, https://doi.org/10.1002/jcb.29530